Choose Your language:
- Testimonials
-
great service thanks
- andrew
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- DARA BioSciences Acquires Oncogenerix, Exclusive Rights For Soltamox-Quick Facts - NASDAQ
- DARA BioSciences Acquires Oncogenerix, Exclusive Rights For Soltamox-Quick FactsNASDAQ(RTTNews
- Oncologists Need Long-Term Perspective with Breast Cancer Adjuvant Hormonal ... - Clinical Oncology News
- Clinical Oncology NewsOncologists Need Long-Term Perspective with Breast Cancer Adjuvant Hormonal
- Musculoskeletal Side Effects From Breast Cancer Treatment Are Not Long Term - Medical News Today
- Musculoskeletal Side Effects From Breast Cancer Treatment Are Not Long TermMedical News TodayTamoxifen and exemestane are both hormone treatments, and whilst tamoxifen blocks the tumor's ability to use estrogen, aromatase inhibitors, such as exemestane reduce the body's production of estrogen
- The value of mammography breast cancer screening - ABC Online
- The value of mammography breast cancer screeningABC OnlineLarry Solin: Actually the treatments we use for DCIS would be radiation and tamoxifen, but you raise an important point—how low is low enough? In the low risk group the ten year risk was about 12% for local recurrence but only 5% for invasive local
- Breast Tenderness and Breast Cancer Risk with ET/EPT - Medscape
- Breast Tenderness and Breast Cancer Risk with ET/EPTMedscapeTamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study
